I'm still standing firm with the story that I heard, DNDN could be turned down for any off label use and possibly denied completely for all usage. This could become dicey in the following weeks as more info is leaked out from the foes camp...
IMHO, DNDN still will be covered by some but the big payday could become watered down.. of course this is all my opinion and even though I'm hardly ever wrong, there is always the possibility that I might be here.. I actually holding 2500 shares (tally it up saulk) long and hoping for an all clear sign..
"This could become dicey in the following weeks as more info is leaked out from the foes camp"
Let us know when you publish chapter two of your fictional book. NEWS FLASH: DNDN does not even need off-label use to be hugely successful. Provenge is already covered 24/7 for on label usuage by 14 of 15 Medicare regions.
But keep talking your book. You foolishly sold a huge chunk of your position and now the stock has broken out.